Clinical Trials

Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progr

Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Oper

BPGbio Recognized as 2024 'BioTech AI Company of the Year' by BioTech Break

Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Coh

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Vizient Launches Capital Spend Insights to Simplify and Optimize Capital Eq

Simulations Plus and the University of Connecticut Receive New FDA Grant to

Healx announces agreement with Sanofi to seek new rare disease indications

nference Establishes AI Research Partnership with Parabilis Medicines in Co

New Medable AI Capabilities Simplifies Digital Clinical Trial Launch with I

Bruker Corporation to Present at Upcoming Investor Conferences

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Soluti

Koneksa Appoints Eric Luthi as Chief Business Officer

Harrow Partners with Asembia to Enhance Provider and Patient Experience Thr

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (

BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and B

Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Up

Building a World-Class Synthetic Biology Lab: Asymchem’s Self-Developed S

Simulations Plus to Participate in the Stephens Annual Investment Conferenc

Seismic Therapeutic Announces Presentations at Upcoming Scientific and Medi

Vistagen to Present at the 2024 Neuroscience Education Institute Congress